InvestorsHub Logo
Followers 27
Posts 1829
Boards Moderated 0
Alias Born 08/25/2015

Re: nidan7500 post# 186050

Thursday, 03/21/2019 10:18:39 AM

Thursday, March 21, 2019 10:18:39 AM

Post# of 469863
Is schizophrenia on our pipeline? If not it will be soon. I like this:
“The ERP Biomarker Qualification Consortium will run clinical studies to support qualification of the ERP biomarker. The studies are designed to evaluate ERP levels in patients with schizophrenia and healthy adults. Key objectives are to determine baseline measures and evaluate how these measures change in response to pharmaceutical interventions.”

I wonder if trials will be limited to schizophrenia? Will drugs be involved or will this strictly be to help justify ERP as a Biomarker? Very interesting!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News